Top business hubs 2026 by Holafly DUBLIN, Irlande, 03 févr. 2026 (GLOBE NEWSWIRE) — Après le fort rebond de 2025, les entreprises entrent dans une phase plus réfléchie en matière de mobilité professionnelle. Aujourd’hui, tout le monde sait que voyager ne consiste plus à accumuler des kilomètres ou à remplir des agendas : il s’agit […]
GLOBE-NEWSWIRE
CGTN: More than a journey: How Spring Festival travel rush reflects a changing China
The 2026 Spring Festival travel rush begins on February 2 and will run for 40 days, ending on March 13. Ahead of this annual migration, CGTN published a feature article exploring how the event has transcended its role as a transport phenomenon, becoming a unique lens through which to view China’s social transformation. BEIJING, Feb. […]
BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet
MELBOURNE, Australia, Feb. 01, 2026 (GLOBE NEWSWIRE) — BHP has selected 10 early-stage exploration and technology companies for the 2026 BHP Xplor program, marking the largest cohort since the program began and its fourth year of operation. The 2026 cohort brings together junior exploration companies, geoscience organisations, and technology teams that collectively span the discovery […]
BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet
MELBOURNE, Australia, Feb. 01, 2026 (GLOBE NEWSWIRE) — BHP has selected 10 early-stage exploration and technology companies for the 2026 BHP Xplor program, marking the largest cohort since the program began and its fourth year of operation. The 2026 cohort brings together junior exploration companies, geoscience organisations, and technology teams that collectively span the discovery […]
Kyowa Kirin reprend le contrôle du programme de développement et de commercialisation du rocatinlimab, manifestant ainsi son profond engagement visant à répondre aux besoins médicaux non satisfaits dans le domaine de la dermatite atopique
Kyowa Kirin réaffirme sa volonté de développer le rocatinlimab comme un traitement innovant capable d’améliorer significativement la vie des patients, tout en offrant un fort potentiel commercial. L’approche novatrice du rocatinlimab, un traitement expérimental destiné au rééquilibrage des lymphocytes T via le ciblage direct du récepteur OX40 exprimé sur les lymphocytes T pathogènes, semble prometteuse pour la […]